These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2338291)

  • 1. Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.
    Molica S; Alberti A
    Haematologica; 1990; 75(1):75-8. PubMed ID: 2338291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant leukocyte A interferon in B-cell chronic lymphocytic leukemia: in vivo effects on autologous antitumor immunity.
    Schulof RS; Lloyd MJ; Stallings JJ; Mai D; Phillips TM; Jones GJ; Schechter GP
    J Biol Response Mod; 1985 Jun; 4(3):310-23. PubMed ID: 3874930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose "natural" alpha-interferon in B-cell derived chronic lymphocytic leukemia.
    Pozzato G; Franzin F; Moretti M; Tulissi P; Pecorari P; Melato M; Zacchi T; Evangelisti P; Campanacci L
    Haematologica; 1992; 77(5):413-7. PubMed ID: 1483591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of treatment with recombinant interferon alfa on natural killer activity in patients with chronic type B lymphatic leukemia].
    Villamor N; Montserrat E; Urbano-Ispízua A; Ribera JM; Rovira M; Vives Corrons JL; Rozman C
    Sangre (Barc); 1989 Dec; 34(6):485-8. PubMed ID: 2629126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
    N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia.
    Klener P; Háber J; Hausner P
    Neoplasma; 1989; 36(2):215-20. PubMed ID: 2716926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
    Mauro FR; Zinzani P; Zaja F; Gentile M; Vegna ML; Stefoni V; Marin L; Fanin R; Baccarani M; Tura S; Mandelli F
    Haematologica; 2003 Dec; 88(12):1348-57. PubMed ID: 14687987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.
    O'Brien S; Kantarjian H; Beran M; Robertson LE; Koller C; Lerner S; Keating MJ
    Blood; 1995 Aug; 86(4):1298-300. PubMed ID: 7632936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
    Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
    Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with fludarabine of chronic refractory lymphoid leukemia].
    Herrero M; Cabrera JR; Briz M; Forés R; Díez JL; Regidor C; Sanjuán I; Fernández MN
    Sangre (Barc); 1995 Apr; 40(2):115-9. PubMed ID: 7784940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Litchy S; Barton JH; Houston GA; Hermann RC; Bradof JE; Greco FA;
    J Clin Oncol; 2003 May; 21(9):1746-51. PubMed ID: 12721250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
    Toccaceli F; Rosati S; Scuderi M; Iacomi F; Picconi R; Laghi V
    Hepatogastroenterology; 1998; 45(23):1748-52. PubMed ID: 9840140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia: a model for studying the B cell family of diseases.
    Al-Katib A; Berman E; Black P; Koziner B
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
    Stelitano C; Morabito F; Kropp MG; Callea V; Iuliano F; Oriana V; Levato D; Nobile F; Molica S; Brugiatelli M
    Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.